Medicare Enrolled
Dr. Larry Tran, MD
Neurology · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Larry Tran is a neurology specialist in Sugar Land, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 1,423 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tran received a total of $20,245 from 86 pharmaceutical and/or device companies across 1137 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 24% volume in TX
$20,245 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,423
Medicare services
Top 24% in TX for neurology
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
570 | $85 | $236 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
351 | $72 | $286 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $124 | $316 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
70 | $124 | $342 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
69 | $153 | $503 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
55 | $93 | $316 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
38 | $207 | $682 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
33 | $178 | $590 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
30 | $40 | $124 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $57 | $159 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
29 | $156 | $496 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
27 | $119 | $416 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $121 | $363 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $61 | $158 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$20,245
Total received (2018-2024)
Avg $2,892/year across 7 years
Top 16% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,137
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,118
2023
$4,428
2022
$2,991
2021
$2,460
2020
$1,412
2019
$1,681
2018
$2,155
Payments by company (2024)
ABBVIE INC.
$1,253
UCB, Inc.
$532
PFIZER INC.
$378
SK Life Science, Inc.
$262
Alexion Pharmaceuticals, Inc.
$216
Lundbeck LLC
$209
ACADIA Pharmaceuticals Inc
$198
Novartis Pharmaceuticals Corporation
$197
Biogen, Inc.
$184
Neurocrine Biosciences, Inc.
$175
Abbott Laboratories
$162
ARGENX US, INC.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$117
Eisai Inc.
$113
EMD Serono, Inc.
$99
Lilly USA, LLC
$94
SI-BONE, INC.
$93
HOSPIRA, INC.
$88
Merz Pharmaceuticals, LLC
$84
Grifols USA, LLC
$73
MITSUBISHI TANABE PHARMA AMERICA, INC.
$72
Amgen Inc.
$66
JAZZ PHARMACEUTICALS INC.
$59
Aucta Pharmaceuticals, Inc.
$43
TG Therapeutics, Inc.
$39
Genentech USA, Inc.
$34
CATALYST PHARMACEUTICALS, INC.
$26
LivaNova USA, Inc.
$22
HARMONY BIOSCIENCES LLC
$19
PIRAMAL CRITICAL CARE
$18
GENZYME CORPORATION
$16
Azurity Pharmaceuticals, Inc.
$16
InSightec,Inc
$12
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,640
Teva Pharmaceuticals USA, Inc.
$1,562
Novartis Pharmaceuticals Corporation
$1,392
UCB, Inc.
$1,292
AbbVie Inc.
$1,150
SK Life Science, Inc.
$862
PFIZER INC.
$821
Biogen, Inc.
$696
ACADIA Pharmaceuticals Inc
$672
Neurocrine Biosciences, Inc.
$617
Amgen Inc.
$579
Acorda Therapeutics, Inc
$559
Genentech USA, Inc.
$514
GENZYME CORPORATION
$459
EMD Serono, Inc.
$451
Lilly USA, LLC
$444
Allergan, Inc.
$404
US WorldMeds, LLC
$377
Alexion Pharmaceuticals, Inc.
$372
Amneal Pharmaceuticals LLC
$357
Abbott Laboratories
$343
Bausch Health US, LLC
$264
Lundbeck LLC
$254
Eisai Inc.
$226
Biohaven Pharmaceutical Holding Company Ltd.
$225
Harmony Biosciences LLC
$191
Boston Scientific Corporation
$182
Takeda Pharmaceuticals U.S.A., Inc.
$178
Grifols USA, LLC
$157
Biohaven Pharmaceuticals, Inc.
$156
ARGENX US, INC.
$147
Neurelis, Inc.
$144
Horizon Therapeutics plc
$137
Merz Pharmaceuticals, LLC
$133
JAZZ PHARMACEUTICALS INC.
$125
Merz North America, Inc.
$112
Allergan Inc.
$105
SI-BONE, INC.
$93
ARBOR PHARMACEUTICALS, INC.
$89
HOSPIRA, INC.
$88
Kyowa Kirin, Inc.
$86
MITSUBISHI TANABE PHARMA AMERICA, INC.
$72
AQUESTIVE THERAPEUTICS, INC.
$71
Medtronic USA, Inc.
$60
Almatica Pharma LLC
$59
ASSERTIO THERAPEUTICS, Inc.
$56
Greenwich Biosciences, Inc.
$54
BOSTON SCIENTIFIC CORPORATION
$53
Sunovion Pharmaceuticals Inc.
$50
Vanda Pharmaceuticals Inc.
$49
Adamas Pharmaceuticals, Inc.
$48
Egalet US Inc
$48
Corium, LLC
$48
Upsher-Smith Laboratories LLC
$46
Zyla Life Sciences
$45
HARMONY BIOSCIENCES LLC
$44
Aucta Pharmaceuticals, Inc.
$43
Supernus Pharmaceuticals, Inc.
$41
Ipsen Biopharmaceuticals, Inc
$40
E.R. Squibb & Sons, L.L.C.
$39
TG Therapeutics, Inc.
$39
LivaNova USA, Inc.
$39
MDD US Operations, LLC
$37
Strongbridge US INC.
$36
Arbor Pharmaceuticals, Inc.
$35
Janssen Pharmaceuticals, Inc
$32
GRT US Holding, Inc.
$28
Averitas Pharma Inc.
$28
Medtronic, Inc.
$28
Avion Pharmaceuticals
$27
CATALYST PHARMACEUTICALS, INC.
$26
AstraZeneca Pharmaceuticals LP
$24
Avadel CNS Pharmaceuticals, LLC
$23
W. L. Gore & Associates, Inc.
$22
Xeris Pharmaceuticals, Inc.
$22
Avanir Pharmaceuticals, Inc.
$22
PIRAMAL CRITICAL CARE
$18
DePuy Synthes Sales Inc.
$18
Nuvectra Corporation
$16
Azurity Pharmaceuticals, Inc.
$16
Mallinckrodt Hospital Products Inc.
$16
Fujirebio Diagnostics, Incorporated
$15
Zyla Life Sciences, Inc.
$15
IMPEL PHARMACEUTICALS INC.
$15
Impax Laboratories, Inc.
$13
InSightec,Inc
$12
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AGAMREE · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Algovita · Austedo XR · BOTOX · BRIUMVI · Briviact · CARDIOFORM Septal Occluder · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COPAXONE · Cambia · Cenobamate · DUOPA · DYSPORT · Dayvigo · Dhivy · Dysport · EMGALITY · EPIDIOLEX · EVUSHELD · Edarbyclor · Epidiolex · Exablate · Fintepla · GABLOFEN · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HETLIOZ · HORIZANT · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · Ongentys · PAXLOVID · PLEGRIDY · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · SYMPHONY · Solitaire · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
332
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tran is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tran performed 570 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $20,245 from 86 companies across 1,137 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other neurologists in Sugar Land?
Dr. Tran's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Sugar Land
Browse neurologists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology